no other articles link to it . please introduce links to this page from related articles ; try the find link tool for suggestions . december 2011 edge therapeutics industry biotechnology founded 2009 headquarters berkeley heights nj u.s. key people brian leuthner president & ceo r loch macdonald chief scientific officer website http www.edgetherapeutics.com edge therapeutics inc. is a clinical stage biotechnology company that discovers develops and seeks to commercialize novel hospital based therapies capable of transforming treatment paradigms in the management of acute life threatening neurological conditions . eg 1962 edge s lead product candidate has the potential to fundamentally improve patient outcomes and transform the management of aneurysmal subarachnoid hemorrhage or asah which is bleeding around the brain due to a ruptured brain aneurysm . eg 1964 edge s second product candidate is being evaluated as a potential prophylactic treatment in the management of chronic subdural hematoma to prevent recurrent bleeding on the surface of the brain . eg 1962 and eg 1964 both utilize edge s proprietary programmable biodegradable polymer based development platform known as precisa . the precisa platform allows edge to create therapeutics capable of delivering medicines directly to the site of injury providing a novel delivery mechanism that enables targeted and sustained drug exposure while potentially avoiding the systemic dose limiting side effects often associated with current standards of care . contents 1 team 1.1 leadership team 1.2 board of directors 1.3 clinical advisors 2 see also 3 external links 4 references team edit leadership team edit president and chief executive officer ceo brian leuthner chief scientific officer cso r. loch macdonald md ph.d. chief financial officer cfo andrew einhorn chief medical officer cmo herbert j. faleck d.o. chief accounting and operations officer bert marchio board of directors edit president & ceo co founder brian leuthner cso co founder r. loch macdonald md ph.d. board chairman chair of compensation committee sol barer ph.d. board vice chairman isaac blech chair of audit committee james j. loughlin kurt conti robert spiegel m.d. facp anders hove dr. james healy clinical advisors edit chair scientific advisory committee robert s. langer ph.d. see also edit nimodipine subarachnoid hemorrhage vasospasm brain aneurysm traumatic brain injury external links edit businessweek edge therapeutic inc. references edit retrieved from https en.wikipedia.org w index.php title edge therapeutics & oldid 704621904 categories pharmaceutical companies based in new jerseycompanies based in new jerseycompanies listed on nasdaqhidden categories orphaned articles from december 2011all orphaned articles navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page print export create a bookdownload as pdfprintable version languages add links this page was last modified on 12 february 2016 at 15 47 . text is available under the creative commons attribution sharealike license ; additional terms may apply . by using this site you agree to the terms of use and privacy policy . wikipedia is a registered trademark of the wikimedia foundation inc. a non profit organization . privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view